Correlation Between Tarsus Pharmaceuticals and Ikena Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Ikena Oncology, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Ikena Oncology.

Diversification Opportunities for Tarsus Pharmaceuticals and Ikena Oncology

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tarsus and Ikena is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Ikena Oncology go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Ikena Oncology

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.72 times more return on investment than Ikena Oncology. However, Tarsus Pharmaceuticals is 1.72 times more volatile than Ikena Oncology. It trades about 0.21 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.05 per unit of risk. If you would invest  2,617  in Tarsus Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of  2,557  from holding Tarsus Pharmaceuticals or generate 97.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Ikena Oncology

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tarsus Pharmaceuticals and Ikena Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Ikena Oncology

The main advantage of trading using opposite Tarsus Pharmaceuticals and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.
The idea behind Tarsus Pharmaceuticals and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Correlations
Find global opportunities by holding instruments from different markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators